During the past decade, Centro Médico Zambrano Hellion conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 4 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Médico Zambrano Hellion" #1 collaborator was "Breast International Group" with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Austrian Breast & Colorectal Cancer Study Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Centro Médico Zambrano Hellion" are "Breast Cancer" (3 trials), "Breast Neoplasms" (2 trials), "Triple Negative Breast Cancer" (2 trials), "Early Breast Cancer" (1 trials) and "HER2-Positive Early Breast Cancer" (1 trials). Many other conditions were trialed in "Centro Médico Zambrano Hellion" in a lesser frequency.

Most popular intervention types in "Centro Médico Zambrano Hellion" are "Drug" (11 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (4 trials), "Atezolizumab" (2 trials), "Cyclophosphamide" (2 trials), "Docetaxel" (2 trials) and "Exemestane" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centro Médico Zambrano Hellion" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Centro Médico Zambrano Hellion". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Centro Médico Zambrano Hellion, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centro Médico Zambrano Hellion, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".